Drug & intervention

baricitinib

RxCUI 2047232

Clinical trials7

Recruiting2

Related conditions10

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

7 shown

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)NCT07222332 · 2026-02-05

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsNCT07222137 · 2026-01-12

Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket TrialNCT05189106 · 2022-12-05

Baricitinib in Hospitalized Covid-19 Patients With Diabetes MellitusNCT04970719 · 2021-07-10

Baricitinib in New-onset Type 1 DiabetesNCT04774224 · 2020-10-30

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney DiseaseNCT01683409 · 2012-08-01

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisNCT01490632 · 2011-12-01

Conditions being studied

Diabetes Mellitus, Type 12 Alzheimer Disease1 Amyotrophic Lateral Sclerosis1 COVID-19 Pneumonia1 Diabetic Kidney Disease1 Mild Cognitive Impairment1 Psoriasis1 Skin Diseases1 Skin Diseases, Papulosquamous1 Type 1 Diabetes1

Research locations

PhiladelphiaPennsylvania, United States4 OsakaJapan3 BirminghamUnited Kingdom2 BronFrance2 BrusselsBelgium2 CambridgeUnited Kingdom2 CharlottesvilleVirginia, United States2 EdegemBelgium2 FlorenceItaly2 FukuokaJapan2 HaifaIsrael2 HanoverGermany2

Leading sponsors

Eli Lilly and Company4 Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders1 Massachusetts General Hospital1 St Vincent's Institute of Medical Research1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.